• OPEN AN ACCOUNT
Indian Indices
Sensex
78,094.64 166.49
( 0.21%)
Global Indices
Nasdaq
52,226.10 610.96
(1.18%)
Dow Jones
7,460.10 122.95
(1.68%)
Hang Seng
64,316.33 2,448.90
(3.96%)
Nikkei 225
10,879.26 -18.01
(-0.17%)
Forex
USD-INR
95.69 -0.03
(-0.03%)
EUR-INR
109.15 0.26
(0.24%)
GBP-INR
127.35 0.13
(0.10%)
JPY-INR
0.58 0.00
(0.09%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

piramal capital & housing finance ltd
Novartis India standalone net profit declines 13.82% in the March 2026 quarter
May 12,2026
Net profit of Novartis India declined 13.82% to Rs 25.25 crore in the quarter ended March 2026 as against Rs 29.30 crore during the previous quarter ended March 2025. Sales rose 7.95% to Rs 90.55 crore in the quarter ended March 2026 as against Rs 83.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 7.65% to Rs 93.18 crore in the year ended March 2026 as against Rs 100.90 crore during the previous year ended March 2025. Sales declined 0.54% to Rs 354.33 crore in the year ended March 2026 as against Rs 356.27 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales90.5583.88 8 354.33356.27 -1
OPM %22.7728.51 -26.5625.66 -
PBDT30.5634.42 -11 131.61132.61 -1
PBT30.1433.89 -11 129.66130.42 -1
NP25.2529.30 -14 93.18100.90 -8